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Background: Grb2 acts as an adaptor protein in the trans- 
duction of signals from receptor tyrosine kinases to Ras. It 
binds to phosphotyrosine on the cytoplasmic tail of cell- 
surface receptors via its central SH2 domain, and to its 
immediate downstream target, SOS, via two SH3 domains. 
The basis of the Grb2-Sos interaction is not fully under- 
stood. We previously proposed a model for SH3 domain 
binding specificity, based on two solution structures of the 
Src SH3 domain complexed with high-affinity ligands, in 
which the ligands are bound in a polyproline type II con- 
formation in two distinct orientations, class I and class II. 
Here, we have used this model to predict the identity and 
orientation of Grb2 SH3 ligands in the human SOS protein. 
Results: Six contiguous fragments from the carboxy-ter- 
minal portion of hS#os (amino acids lOOO-1333), each 
containing a single potential SH3 binding site, were 
expressed in E. coli as GST fusion proteins. Four of these 
proteins were predicted to associate with SH3 domains. 
The amino-terminal Grb2 SH3 domain was shown to 
bind strongly to only these four fragments. 
Conclusions: We have used a general model for SH3- 
ligand interactions to predict the nature of Grb2 SH3 
interactions with the hSos protein. Comparison of the 
four hSos sequences that bind Grb2 revealed a preference 
for the PXXPXR motif, consistent with the predicted 
class II-type binding interaction.The interaction between 
Grb2 and hSos peptides is predominantly via the amino- 
terminal SH3 domain, although the carboxy-terminal 
SH3 domain may increase the overall stability of the 
Grb2-hSos complex. 
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Introduction 
Growth factor receptor-bound protein-2 (Grb2) is the 
most extensively characterized adaptor protein used in 
growth factor-stimulated signaling pathways [l-4]. It 
functions in receptor tyrosine kinase-initiated signaling 
pathways [5] by linking cell-surface receptors to Ras via 
the human Son-of-Sevenless (hSos) protein, a guanine 
nucleotide exchange factor [6]. Grb2 is a 25 kDa protein 
composed of 217 amino acids with a central Src homol- 
ogy 2 (SH2) domain flanked by two Src homology 3 
(SH3) domains. Its upstream targets in the transduction 
of signals from the plasma membrane include the epi- 
dermal growth factor receptor (EGFR) and the acti- 
vated, receptor-associated protein She (2,7,8). The 
human Grb2 gene was c:loned on the basis of the associ- 
ation between the protein it encoded and the tyrosine- 
phosphorylated cytoplasmic domain of the activated 
EGFR [l].This interaction was found to be mediated by 
the SH2 domain of Grb2. SH2 domains - structural 
modules found in many other proteins involved in signal 
transduction - bind phosphorylated tyrosine residues 
in specific primary sequence contexts [9,10].The Grb2 
SH2 domain binds to the sequence Tyr-X-Asn-X 
(where X can be a variety of amino acids) in a phospho- 
rylation-dependent manner. GRB-3.3, an alternatively 
spliced variant that lacks part of the SH2 domain, was 
recently shown to be expressed in high levels in the 
developing thymus and has been implicated in the 
induction of apoptosis in thymocytes [l 11. 
The Grb2 SH3 domains are necessary for the interaction 
between Grb2 and the guanine nucleotide exchange 
factor hSos [6,12]. SH3 domains are modular units found 
within a variety of proteins involved in either signal 
transduction or the cytoskeleton, or both.They are com- 
posed of -60 amino acids and have been shown to effect 
protein-protein association by binding proline-rich 
sequences [9,13,14]. The structures of unliganded SH3 
domains from a number of different proteins have been 
determined [15-231. The solution structure of the SH3 
domain of PI3K bound to a peptide ligand has been 
determined using NMR [24]. More recently, Abl and 
Fyn SH3 domain complexes have been solved by crystal- 
lographic means [25], and the solution structure of the 
SH3 domain from Src complexed to two proline-rich 
peptides in two different orientations has been solved by 
NMR [26]. Sequence similarity between the Src and 
Grb2 SH3 domains, as well as the similarity of their 
ligands, has been used to predict the orientation of the 
Grb2 amino-terminal SH3 domain complexed with a 
peptide derived from hSos [26]. 
hSos, the human homolog of the Drosophila son-of-seven- 
less guanine nucleotide exchange factor, contains a central 
domain that is highly conserved among members of the 
CDC25 family of guanine nucleotide exchange factors 
and a proline-rich carboxy-terminal domain [8]. The 
region of hSos necessary for Grb2 binding was mapped 
to the proline-rich portion of the protein and candidate 
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sequences within this region were identified [3]. 
Although it is certain that Grb2 binds to proline-rich 
regions of hSos, it remains unclear whether both SH3 
domains bind to the same or different sequences in this 
domain. Genetic studies on Caenorhabditis elegans and 
Drosophila homologs of Grb2 have identified mutations in 
each of the SH3 domains that render the protein inactive 
[27-291. The studies described in this report were 
designed to determine the role of each SH3 domain in 
the formation and stability of the Grb2-hSos complex. To 
do this,we have used a general model for SH3-ligand 
interactions [26], which proposes that the two classes of 
SH3 ligands, class I and class II, have distinct, defined 
binding modes and recognizable motifs. This model cor- 
rectly predicts the identity of the hSos peptides that bind 
to Grb2, all of which are class II-type peptides. 
Results 
Cloning and expression of SH3 domains 
The cDNA encoding the Grb2 protein was amplified 
from a human brain stem cDNA library, using published 
cDNA sequences [l]. The PCR primers were designed 
with restriction sites to allow efficient subcloning of the 
amplified DNAs into the pGEX-2TK vector. In addition 
to the intact Grb2 protein, individual domains were also 
cloned into the expression vector. Grb2 (amino acids 
l-217), the amino-terminal SH3 domain plus the SH2 
domain (Grb2 l-160) and carboxy-terminal SH2-SH3 
(Grb2 55-217) proteins were overexpressed in E. coli strain 
BL-21 as glutathione-S transferase (GST) fusion proteins 
(Fig. 1). The fusion proteins were purified by glutathione 
agarose chromatography. The carboxy-terminal SH3 
domain was proteolytically unstable when expressed as a 
GST fusion protein. To overcome this problem, the 
carboxy-terminal SH3 domain was expressed as a fusion 
with its neighboring SH2 domain, resulting in increased 
stability.The SH2 domain was found to have no effect on 
Fig. 1. Autoradiograph of 32P-phosphorylated GST fusion pro- 
teins. Plasmids were constructed to encode GST fused to amino 
acids 1-217 of Grb2 &ST-GRB2) or to individual SH3 domains 
from Grb2. GST-NSH3 designates the fusion protein containing 
the amino-terminal SH3 domain (amino acids l-l 60 of Grb2), 
and GST-CSH3 containing the carboxy-terminal SH3 domain 
(amino acids 55-217 of Grb2). 
Fig. 2. The identification of potential Grb2 SH3 binding sites in 
the carboxy-terminal domain of hSos. Each peptide contains a 
PXXP motif. The CDC25 homology region contains the guanine 
nucleotide exchange factor catalytic domain. 
the binding of the amino-terminal SH3 domain to a syn- 
thetic peptide ligand when the binding ability of the 
amino-SH3-SH2 ,polypeptide was compared to that of a 
fusion protein containing the SH3 domain alone (data not 
shown). The binding activities of the amino-terminal 
SH3-SH2 and the carboxy-terminal SH2-SH3 GST 
fusion proteins are therefore considered to be due solely to 
the SH3 domain in the remainder of this paper. 
Small scale expression and 32P-labeling of Crb2 proteins 
The labeling and purification procedures were adapted 
from Kaelin et al. [30]. For small scale expression, 20-ml 
cultures of E. coli harboring the expression plasmids 
were induced with isopropyl-P-D-thiogalactopyra- 
noside (IPTG)’ at 37 “C for 1 h. The bacterial lysates 
were incubated with glutathione agarose.The 32P-label- 
ing reaction was carried out while the recombinant 
GST fusion protein was bound to the resinThe kinase 
was removed by repeated washing and the labeled 
protein was eluted with reduced glutathione.The GST 
fusion protein was used for the binding assays (Fig. 1). 
The probe concentrations were adjusted to give the 
same specific activity (dpm) for each experiment. The 
levels of 32P incorporation were similar for the five 
GST-SH3 fusion proteins. 
Cloning and expression of hSos peptides 
The cDNA encoding the hSos protein was cloned from 
a human T-cell (Jurkat) cDNA library using a cDNA 
probe generated by PCR [8]. Individual regions were 
amplified using PCR and subcloned into pGEX-2TK 
(Fig. 2). All constructs were fully sequenced in both 
directions. Cultures of E. coli strain BL21 transformed 
with the hSos expression plasmids were induced with 
IPTG at room temperature for 10 min prior to cell 
lysis.The induction was carried out for a short period 
of time, since at longer induction times the expression 
levels varied dramatically (data not shown). Bacterial 
lysates were separated by electrophoresis through a 
12 % polyacrylamide gel and transferred to an 
Immobilon-P membrane. The level of protein expres- 
sion was determined by Western blotting with poly- 
clonal anti-GST antibodies (Fig. 3). In addition to the 
hSos proteins, two negative controls, GST alone and a 
GST fusion with FKBP25 (FK506 binding protein 25), 
were included. 
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Fig. 3. Exoression of hSos fragments. (a) 7 
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taining FKBP25. 
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Binding studies using 32P-labeled Grb2 fusion proteins 
Proteins immobilized on identical Immobilon-P mem- 
branes were fully denatured with 6M guanidinium 
hydrochloride. The denaturant was removed by sequen- 
tial dilution.The membranes were blocked with non-fat 
dry milk and incubated with the 32P-labeled SH3 pro- 
teins.The membranes were washed to remove unbound 
probe and exposed to film. 
The full length Grb2 protein bound to fragments SOS2, 
SOS3, SOS4 and SOS6 (Fig. 4a). There was no 
detectable binding to SOS1 and SOS5.The amino-ter- 
minal SH3 domain showed the same pattern of hSos 
fragment binding (Fig. 4b). The carboxy-terminal SH3 
domain did not interact with any of the SOS peptides 
under these conditions (Fig. 4~). 
Discussion 
Proline-rich peptides have been shown to form stable 
complexes with SH3 domains. In each of the complexes 
reported to date, the ligands are bound in a polyproline 
type II (PPII) helix conformation. The PPII helix has 
three residues per turn with amino acids i and i+3 occu- 
pying equivalent positions along the edge of the helix, as 
illustrated in Fig. 5.The interface of the core PPII helix 
and its SH3 receptor is formed by two edges of the helix 
with residues i, i+2, i+-3, i+5 and i+6 (where i is the 
residue bound to pocket PI) interacting with three dis- 
tinct sites within the binding domain [26].The first site, 
designated P,, contains a highly conserved acidic amino 
acid that can form a salt bridge with an Arg residue that 
is present at position i in many SH3 ligands. The Abl 
SH3 domain lacks the conserved acidic residue, however, 
and its ligands, 3BP-1 and 3BP-2, have hydrophobic 
groups in place of the Arg [25,31]. 
Recent structural studies using the Src SH3 domain 
have shown that two distinct binding orientations (class 
I and class II) are possible (Fig. 5).Amino acids i+2 and 
i+3 in a class I mode or i-2 and i-3 in a class II mode 
(Figs 5,6 and discussion below) interact with pockets P, 
and P,,, respectively; these pockets together constitute 
the second binding site. Amino acids i+5 and i+6 (or 
i-5 and i-6) interact with the third binding site, pockets 
P,, and P,,, (Fig. 6). 
The class I orientation has been observed in complexes 
of PI3K, Fyn and Abl SH3 domains [24,25] as well as the 
Src complex with the RLP2 peptide [26]. The position 
of the Arg residue in class I ligands (with the exception 
of the Abl SH3 ligands, as mentioned above) is at the 
amino-terminus of the peptide. The interaction of the 
Arg with conserved acidic residues, therefore, orients the 
peptide so that the amino-terminus is located near the P, 
43 
Fig. 4. Filter binding of GST fusion pro- 
teins to hSos fragments. (a) Binding of 
hSos fragments to GST fusion proteins *’ -4!ulP- . . 
containing the amino-terminal SH3 
domain; (b) binding to GS’T fusion pro- 
teins containing full-length Grb2; (c) 
binding to GST fusion proteins contain- 
ing the carboxy-terminal SH3 domain. 
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(a) 
SH3 ligand binding site 
(b) 
SH3 ligand binding site 
Fig. 5. Mnemonic device for analyzing 
SH34igand interactions. (a) Class I 
SH3-ligand interaction, showing con- 
served SH3 residues. (b) Class II 
SH34igand interaction. The two orien- 
tations of ligands are noted by the num- 
bering system and the labels C and N, 
signifying the carboxy- and amino-ter- 
minal amino acids. Optimal residues for 
seven positions of the core binding 
element are depicted. 
pocket. In class II ligands, the Arg residue is at the domain and Glu174 in the carboxy-terminal domain) 
carboxyl terminus of the peptide, so the peptide binds in suggests they should both be able to bind to Arg-con- 
the opposite orientation. It is important to note that in taining ligands in either the class I or class II orientation. 
both types of complexes the P,,/Pv and PI,,/P,, pockets Alignment of the amino acid sequences of SH3 domains 
are occupied by XP dipeptide fragments (where X is a 
hydrophobic amino acid and P is Pro) rather than PX 
dipeptides, which have been shown to have no measur- 
able binding affinity [26]. The more compact nature of 
the XP dipeptide compared to the corresponding PX 
one results in topographical complementarity to the 
second and third pockets. 
Recently, we proposed a general model for formation of a 
complex between an SH3 domain and a peptide ligand 
[26]. On the basis of this model, we predicted that a syn- 
thetic decapeptide derived from SOS2 (N-Ac-VPPPVP- 
PRRR-NH,, hereafter called ‘the SOS2 peptide’) would 
bind to the amino-terminal SH3 domain of Grb2 in a 
class II orientation. Binding studies using mutated peptide 
ligands supported the prediction that the amino-terminal 
SH3 domain binds to SOS2 in a class II orientation. Fig. 6. A schematic representation of the four hSos peptides that 
bind to Grb2 amino-terminal SH3 in a oroline tvpe II helix con- 
Here, we have used the guidelines for structure predic- formation. The Arg residue (red) forms a salt bridge with Glul6 
tion proposed in [26] to predict which of six hSos frag- (amino-terminal SH3) or Clul74 (carboxy-terminal SH3). This 
ments will bind to Grb2, and in which orientation.The 
interaction dictates the orientation of the complex and determines 
presence of a conserved, glutamic acid residue in both 
the identity of the XP dipeptides that occupy the P,JPv and P,#,v 
binding pockets. Similar interactions are present in the lower- 
Grb2 SH3 domains (Glu16 in the amino-terminal SH3 affinity complexes of the carboxy-terminal SH3. 
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Fig. 7. Amino acid sequence alignment 
of amino- and carboxy-terminal SH3 
domains from human (Grb2),. Drosophila 
(Drk) and C. elegans (Sem5) as well as v- 
Src and c-Abl. Residues highlighted in 
blue are conserved among most SH3 
domains. The residues in pink and green 
are conserved in the carboxy- and 
amino-terminal SH3 domains respec- 
tively. The conserved glutamic acid 
residue in the amino- (Glu16) and 
carboxyl- (Glu174) domains is high- 
lighted in yellow. Bold designates the 
residues that line the ligand-binding site. 
1 
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(Fig. 7) shows that the human Grb2 amino-terminal SH3 
is more closely related to the C. elegans Sem-5 amino- 
terminal SH3 and Drosophila Drk amino-terminal SH3 
than to the human Grb2 carboxy-terminal SH3 [32]. 
Thus the conservation of the glutamic acid residue may 
be functionally significant, as it is not part of an overall 
high degree of similarity between the amino- and 
carboxy-terminal SH3 domains. 
Using the above considerations, the SOS1 and SOS5 
peptides are predicted to be poor Grb2 ligands. Despite 
the presence of an amino-terminal arginine in Sosl, it is 
seen to be out of regis,ter for a class I binding mode 
(Fig. 8). However, four !Sos-derived peptides - SOS2, 
SOS3, SOS4 and SOS6 - contain the class II consen- 
sus features: a carboxy-terminal arginine and two XP 
dipeptides at positions i--3, i-2 and i-6, i-5. We there- 
fore predicted that botb SH3 domains should bind to 
fragments SOS2, SOS3, SOS4 and SOS6 in a class II 
orientation, as shown in Fig. 6, and that SOS1 and 
SOS5 should not bind in either orientation.These pre- 
dictions are consistent with the results of the filter 
binding studies. The proline-rich regions of the six hSos 
derived fragments are shown in Fig. 8. The four frag- 
ments that bind, unlike the two that do not, conform to 
Class I: RPXPPXP 
Class II: XPPXPPR 
SOS2 PVPPPVPPRRRE 
SOS3 DSPPAIPPRQPT 
SOS4 ESPPLLPPREPV 
SOS6 IAGPPVPPRQST 
SOS1 PRTPLTPPPASG 
SOS5 SPSPFTPPPPQT 
the general model for SH3-ligand complexes. We 
propose that the carboxy-terminal arginine of the four 
binding fragments binds in the P, pocket that contains 
the conserved acidic residue (Glu16 of the amino-ter- 
minal SH3 and Glu174 of carboxy-terminal SH3) _ This 
interaction orients the peptide in the binding site and it 
determines the register for the proline residues that fill 
the P,,/Pv and P,l,/P,v pockets. These are occupied by 
VP and PP in SOS2, IP and PP in SOS3, LP and PP in 
SOS4, andVP and GP in SOS6. 
The filter binding assay also demonstrates differences 
between the two SH3 domains of Grb2 in binding to 
hSos peptides. We have previously shown [32] that the 
association between the amino-terminal SH3 domain of 
Grb2 and the SOS2 peptide has a K, of 5.7 /.tM, whereas 
the carboxy-terminal SH3 domain binds more weakly, 
with a K, of 39 pM.The filter binding assay was capable 
of detecting the stronger interaction, but not the weaker 
one.The affinity of the intact Grb2 protein for an immo- 
bilized peptide containing the PPPVPPR sequence 
derived from SOS2 has been determined, and found to 
have a K, of 25 nM, using the BioSensor technology 
(BIAcore Pharmacia) [33]. In the BIAcore experiment, 
the ligand is immobilized on a surface. It is likely that the 
observed K, is due to binding of both SH3 domains to 
different molecules of the same peptide. Similarly, when 
intact Grb2 binds to the intact hSos protein, it is likely 
that both SH3 domains bind to different peptides. We 
have attempted to measure the affinity of Grb2 for the 
SOS2 peptide using the fluorescence enhancement 
method.The data appear to reflect the independent asso- 
ciation of the two SH3 domains with two independent 
binding constants (T.K. Chen and S.L.S., unpublished 
results), similar to the binding constants seen when the 
associations between individual SH3 domains and 
hSos-derived peptides are studied independently [32]. 
It is likely that the two Grb2 SH3 domains bind cooper- 
Fig. 8. Amino acid sequence alignment of proline rich peptides atively to hSos [34], allowing two relatively weak interac- 
from hSos. Top, typical class I and class II motifs. SOS2, SOS3, tions to give a high affinity comp1ex.A functional model 
SOS4 and SOS6 bind to the SH3 domains of Crb-2 in a class II of the Grb2-hSos association is shown in Fig. 9. We 
orientation. Critical residues are indicated with arrows. SOS1 
and SOS5 do not bind. The SOS1 peptide contains a potential 
predict that each of the SH3 domains forms a complex 
class I sequence (Arg at the ,amino-terminus of the PXXP motif). 
with one of the hSos peptides found here to be capable 
Class I binding of this peptide would result in the placement of a of binding to the amino-terminal SH3 domain (SOS2, 
PX dipeptide (TP) in the P,,/‘P, binding site instead of the pre- SOS3, SOS4 or SOS6).The association of a single SH3 
ferred XP dipeptide, and is therefore predicted to be disfavored. domain - possibly the amino-terminal domain, due to 
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Fig. 9. A functional model for GrbZ-hSos association. The con- 
served Glu residues (red) form salt bridges with the Arg residues 
(blue). This interaction determines the orientation of both 
binding interactions, which are both predicted to be class II- 
type interactions. 
its higher affinity - reduces the entropic cost associated 
with the formation of the second SH3-ligand complex, 
enhancing the overall binding. Both of the Grb2-hSos 
interactions are predicted to have class II orientation. 
Indeed, recent structural investigations [35-381 have con- 
firmed the class II orientation of SOS peptides bound to 
Grb2 amino- and carboxy-terminal SH3 domains. 
Significance 
Using a predictive model for SH34igand interac- 
tions we have examined the interaction of Grb2 
with hSos. The general model for complexes 
between SH3 domains and proline-rich ligands was 
developed by analyzing the structures of the Src 
SH3 domain and two different high-afhnity ligands. 
The two classes of complexes observed differ most 
significantly in their peptide orientation. Class I 
ligands contain an Arg residue at the amino termi- 
nus of a Pro-containing region, while in class II 
ligands the Arg is at the carboxyl terminus.The Arg 
residue binds, via a salt bridge, to a conserved 
acidic amino acid in the P, pocket of the SH3 
domain, thereby determining the orientation of the 
peptide.These results were generalized to provide a 
predictive tool to analyze SH3 ligand complexes. 
The Grb2-hSos complex is the most biologically 
significant SH3-mediated association identified to 
date. It has a crucial role in linking growth factor 
receptors to the Ras-mediated signaling pathway, 
resulting in cellular growth and differentiation. 
The interaction between Grb2 and hSos is medi- 
ated by two Grb2 SH3 domains, and hSos con- 
tains several potential SH3 binding sequences. 
Here, we have used our predictive model to iden- 
tify the SH3 ligands within hSos, and to predict 
the orientations of the resulting complexes. 
Indeed, of six possible SH3 ligands only four, as 
predicted, bound to Grb2 SH3 domains. Of the 
two Grb2 SH3 domains, the amino-terminal one 
appears to be the more important. The results 
presented here provide insight into the Grb2-hSos 
interaction, and demonstrate that it is possible to 
identify potential SH3 binding sites within 
proline-rich regions on the basis of the primary 
amino acid sequence of the ligand. 
Materials and methods 
Materials 
All chemicals were purchased from Sigma Chemical Co. 
Restriction enzymes were purchased from Boehringer 
Mannheim. Oligonucleotides were synthesized on an Applied 
Biosystems 381A DNA synthesizer. The Immobilon-P mem- 
brane was purchased from Millipore. Heart muscle kinase was 
purchased from Sigma. The 32P-y-ATP (6000 Ci mmol-‘) was 
purchased from Amersham. Reduced glutathione, glutathione- 
agarose and polyclonal anti-GST antibodies were purchased 
from Molecular Probes Inc. All sequencing reactions were per- 
formed using the Sequenase kit from USBiochemical. The 
pGEX-2TK vector was kindly provided by Professor William 
G. Kaelin Jr. (Harvard Medical School). 
Cloning of Grb2 
The cDNA encoding the entire Grb2 protein was amplified 
using the polymerase chain reaction from a human brain stem 
cDNA library (Clontech) using nested primers based on the 
published nucleotide sequence. The forward (5’-AGG CTA 
GGA TCC ATG GAA GCC ATC AAA3’) and reverse (5’- 
GGA ATC TGA ATT CCC TTA GAC GTT CCG GTT 
CAC GGG-3’) PCR primers contained engineered BarnHI 
and EcoRI sites, respectively. The amplified PCR product was 
digested with BamHI and EcoRI and cloned directly into the 
BamHI/EcoRI digested pGEX-2TK vectorThe sequence was 
confirmed by dideoxy sequencing in both directions using 
vector-based sequencing primers as well as Grb2 specific 
primers.The pGEX-2TK:Grb2 plasmid was used to transform 
competent E. coli BL-21. 
Large-scale overexpression of Grb2 protein and fragments 
Overexpression of the GST-Grb2 fusion proteins was accom- 
plished by inoculating 1.2 1 of Luria broth containing ampi- 
cillin, 100 mg 1-l) with a 4 ml overnight culture. The bacteria 
were allowed to grow at 37 “C until OD,,, = 0.8 and were 
treated with 1 mM IPTG.The culture was induced for 6 h at 
which time the cells were pelleted (4000 rpm, 30 min, 4 “C). 
The cells were resuspended in 50 ml lysis buffer (50 mM Tris- 
HCl, pH 8.0; 10 mM EDTA and 1 mM phenylmethylsulpho- 
nyl fluoride (PMSF) and pulse sonicated (3 x 30 s).The lysates 
were clarified by centrifugation (15 000 rpm, 30 min, 4 “C) 
and the supernatant was applied directly to a column contain- 
ing 10 ml glutathione-agarose. The column was washed with 
ten volumes of phosphate-buffered saline (PBS) and the fusion 
protein was eluted with 5 mM glutathione in 50 mM Tris-HCl 
pH 8.0. Glutathione was removed by dialysis against four 
changes of 150 mM NaCl, 20 mM Tris-HCl pH 8.0. 
Small scale expression and 32P labeling of GST-SH3 
fusion proteins 
The individual amino-terminal and carboxy-terminal SH3 
domains from Grb2 were subcloned into the pGEX-2TK 
vector and confirmed by sequencing. The labeling procedure 
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was adapted from Kaelin et al. [30]. Overnight cultures (2 ml) 
of transformed E. coli were diluted I:10 and grown for 2 h at 
37 “C. The cultures were induced with 1 mM IPTG and 
grown for an additional 3 h at 37 ‘C.The cells were collected 
by centrifugation (4000 rpm, 5 min, 4 “C) and resuspended in 
2 ml NETN (100 mM NaCl, 20 mM Tris-HCl, 1 mM EDTA, 
0.5 % NP-40) and sonicated (3 x 30 set) at 4 OC.The bacterial 
debris was pelleted (14,000 rpm, 5 min, 4 “C) and the super- 
natant was mixed with 100 ~1 glutathione-Sepharose (2 h, 
4 “C). The mixture was incubated for 2 h and the resin was 
washed with 3 x 1 ml NETN and once in heart-muscle kinase 
(HMK) buffer (100 mM NaCl, 20 mM Tris-HCl pH = 7.5, 
12 mM MgCl,) and finally resuspended in 100 ~1 reaction 
mixture containing 10 ~1 10x HMK buffer, 1 /.~l 1 M dithio- 
threitol (DTT), 4 ~1 resuspended HMK and 8 ~1 32P-yATP. 
The reaction was incubated at 4 “C for 1 h and stopped with 
the addition of 1 ml HMK stop buffer (IO mM sodium phos- 
phate pH = 8.0, IO mM sodium pyrophosphate, IO mM 
EDTA, and 1 mg ml-’ BSA). The glutathione beads were 
washed with 5 x 1 ml NETN and the phosphorylated proteins 
were eluted with 1 ml glutathione solution (120 mM NaCl, 
100 mM Tris-HCl pH = 8.0, 20 mM reduced glutathione). 
The proteins were analyze’d by SDS-polyacrylamide gel elec- 
trophoresis (SDS-PAGE) and autoradiography (Fig. 2). The 
efficiency of labeling was determined by Bradford protein assay 
and liquid scintillation counting. 
Cloning and expression of hSos fragments 
The gene encoding the human SOS protein was cloned from a 
human T cell (Jurkat) library (Stratagene) using a PCR ampli- 
fied cDNA probe. PCR primers used to generate the cDNA 
probe were designed using the published hSos sequence [8]. 
Additional PCR primers were designed to allow the amplifica- 
tion, subcloning and expression of the six individual hSos pep- 
tides as GST fusion proteins. GST fusion proteins were 
prepared by subcloning the PCR-amplified cDNAs into 
pGEX-2TK vector and confirmed by sequencing. Bacteria 
containing the appropriate plasmids were grown in 2 ml cul- 
tures to an OD,,, = 0.6 and induced with 1 mM IPTG.After 
10 min at 25 ‘C the bacteria were collected by centrifugation 
(10 000 x g, 4 ‘C, IO min) and lysed by boiling in SDS-PAGE 
loading buffer. The proteins were separated on a 12 % 
SDS-PAGE gel and transferred to an Immobilon-P membrane. 
Western blotting with 32P-labeled GST-SH3 fusion proteins 
The membranes were placed protein side up in the blocking 
buffer (25 mM Hepes-KOH pH = 7.7, 25 mM NaCl, 5 mM 
MgCl,, 5 % non-fat dry milk, 1 mM DTT, 0.05 % NP-40) and 
incubated with shaking for 2 h at 4 ‘C.The filters were washed 
with two changes of the denaturing solution (6 M guanidinium 
HCl, 25 mM Hepes-KOH pH 7.7, 25 mM NaCl, 5 mM 
MgCl,, 1 mM DTT) at 4 ‘C.The denaturing solution was seri- 
ally diluted (each time 1:l with 25 mM Hepes-KOH pH 7.7, 
25 mM NaCl, 5 mM MgCl,, 1 mM DTT), until a final guani- 
dinium hydrochloride concentration of 0.187 M was reached. 
Each intervening wash was carried out for 20 min at 4 ‘C.The 
filters were washed with two changes of fresh 25 mM Hepes- 
KOH pH = 7.7, 25 mM NaCl, 5 mM MgCl,, 1 mM DTT 
(10 min washes) and 25 mM Hepes-KOH pH 7.7, 25 mM 
NaCl, 5 mM MgCl,, 1 mM DTT, 5 % non-fat dry milk, 0.05 % 
NP-40 (1 h wash) and finally with 25 mM Hepes-KOH pH 
7.7,25 mM NaCl, 5 mM MgCl,, 1 mM DTT, 1 % non-fat dry 
milk 0.05 % NP-40 (1 h wash).The hybridization was carried 
out at 4 “C by placing the filters in 10 ml hybridization solution 
(20 mM Hepes-KOH pH 7.7, 75 mM KCI, 0.1 mM EDTA, 
2.5 mM MgCl,, 1 % non-fat dry milk, 0.05 % NP-40 and 5 mg 
32P-labeled GST-SH3 protein) for 6 h.The filters were washed 
with three changes of fresh hybridization solution (IO ml), 
covered with Saran wrap and exposed to film. 
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